Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan A Staessen

Showing results (31-40 of 693) with videos related to

Pageof 70
Sort By:
Advances in Chronic Kidney Disease|February 24, 2015
Reducing salt intake for prevention of cardiovascular disease--times are changingKatarzyna Stolarz-Skrzypek, Jan A Staessen
Evidence-Based Nursing|December 6, 2024
Using ethnicity to guide the management of hypertensionDe-Wei An, Jan A Staessen
Environmental Health : a Global Access Science Source|February 21, 2018
Letter to editor: Blood pressure, hypertension and lead exposureWen-Yi Yang, Jan A Staessen
Journal of the American Society of Nephrology : JASN|December 6, 2002
Conventional therapy and newer drug classes for cardiovascular protection in hypertensionJi-Guang Wang, Jan A Staessen
Journal of Clinical Hypertension (Greenwich, Conn.)|January 31, 2003
Benefits of antihypertensive pharmacologic therapy and blood pressure reduction in outcome trialsJi-Guang Wang, Jan A Staessen
Circulation|September 27, 2006
Low-level environmental exposure to lead unmasked as silent killerTim S Nawrot, Jan A Staessen
Blood Pressure Monitoring|October 1, 2003
Relation between left ventricular mass and systolic blood pressure at baseline in the APTH and THOP trialsElly Den Hond, Jan A Staessen, , et al.
Lancet (London, England)|June 23, 2004
Convergence of atherosclerosis and Alzheimer's diseaseWillem H Birkenhäger, Jan A Staessen
The Lancet. Neurology|May 23, 2006
Antihypertensives for prevention of Alzheimer's diseaseWillem H Birkenhäger, Jan A Staessen
Pharmacogenomics|April 30, 2003
Pharmacogenomics of primary hypertension--the lessons from the past to look toward the futureGiuseppe Bianchi, Jan A Staessen, Ferrari Patrizia
Pageof 70

Showing results (31-40 of 693) with videos related to

Sort By:
Pageof 70
Advances in Chronic Kidney Disease|February 24, 2015
Reducing salt intake for prevention of cardiovascular disease--times are changingKatarzyna Stolarz-Skrzypek, Jan A Staessen
Evidence-Based Nursing|December 6, 2024
Using ethnicity to guide the management of hypertensionDe-Wei An, Jan A Staessen
Environmental Health : a Global Access Science Source|February 21, 2018
Letter to editor: Blood pressure, hypertension and lead exposureWen-Yi Yang, Jan A Staessen
Journal of the American Society of Nephrology : JASN|December 6, 2002
Conventional therapy and newer drug classes for cardiovascular protection in hypertensionJi-Guang Wang, Jan A Staessen
Journal of Clinical Hypertension (Greenwich, Conn.)|January 31, 2003
Benefits of antihypertensive pharmacologic therapy and blood pressure reduction in outcome trialsJi-Guang Wang, Jan A Staessen
Circulation|September 27, 2006
Low-level environmental exposure to lead unmasked as silent killerTim S Nawrot, Jan A Staessen
Blood Pressure Monitoring|October 1, 2003
Relation between left ventricular mass and systolic blood pressure at baseline in the APTH and THOP trialsElly Den Hond, Jan A Staessen, , et al.
Lancet (London, England)|June 23, 2004
Convergence of atherosclerosis and Alzheimer's diseaseWillem H Birkenhäger, Jan A Staessen
The Lancet. Neurology|May 23, 2006
Antihypertensives for prevention of Alzheimer's diseaseWillem H Birkenhäger, Jan A Staessen
Pharmacogenomics|April 30, 2003
Pharmacogenomics of primary hypertension--the lessons from the past to look toward the futureGiuseppe Bianchi, Jan A Staessen, Ferrari Patrizia
Pageof 70